Citi Pharma Limited reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported sales was PKR 2,688.73 million compared to PKR 2,748.14 million a year ago. Net income was PKR 92.77 million compared to PKR 207.45 million a year ago. Basic earnings per share from continuing operations was PKR 0.41 compared to PKR 0.92 a year ago.
For the nine months, sales was PKR 8,859.6 million compared to PKR 7,589.37 million a year ago. Net income was PKR 533.4 million compared to PKR 550.69 million a year ago. Basic earnings per share from continuing operations was PKR 2.33 compared to PKR 2.43 a year ago.